TipRanks
Advertisement
Advertisement

DE:4FR Stock Latest News

Faron reappoints key members to Nomination Board as cancer immunotherapy pipeline advances
Company AnnouncementsFaron reappoints key members to Nomination Board as cancer immunotherapy pipeline advances
1d ago
Faron defers EUR 1.4m convertible bond amortisation to bolster funding for cancer immunotherapy
PremiumCompany Announcements
Faron defers EUR 1.4m convertible bond amortisation to bolster funding for cancer immunotherapy
7d ago
Faron resets IPF warrant terms as convertible bonds amortised
PremiumCompany Announcements
Faron resets IPF warrant terms as convertible bonds amortised
20d ago
Faron Buy Rating Reiterated as Bexmarilimab Advances to Fully Funded Pivotal Trials; £10 Price Target Maintained
PremiumRatings
Faron Buy Rating Reiterated as Bexmarilimab Advances to Fully Funded Pivotal Trials; £10 Price Target Maintained
1M ago
Faron Pharmaceuticals Sets Date for Half-Year 2026 Financial Results
PremiumCompany Announcements
Faron Pharmaceuticals Sets Date for Half-Year 2026 Financial Results
2M ago
Faron Uses Treasury Shares to Settle EUR 1.58m Convertible Bond Amortisation
PremiumCompany AnnouncementsFaron Uses Treasury Shares to Settle EUR 1.58m Convertible Bond Amortisation
2M ago
Patrick Trucchio Reaffirms Buy on Bexmarilimab, Citing Robust Clinical Data, Valuation Upside and Unchanged £10 Price Target
Premium
Ratings
Patrick Trucchio Reaffirms Buy on Bexmarilimab, Citing Robust Clinical Data, Valuation Upside and Unchanged £10 Price Target
2M ago
Faron posts encouraging survival signal in bexmarilimab HR-MDS trial
Premium
Company Announcements
Faron posts encouraging survival signal in bexmarilimab HR-MDS trial
2M ago
Bexmarilimab Progress and Solid-Tumor Milestones Support Reaffirmed Buy Rating and Unchanged £10 Price Target
PremiumRatings
Bexmarilimab Progress and Solid-Tumor Milestones Support Reaffirmed Buy Rating and Unchanged £10 Price Target
3M ago
Faron Pharmaceuticals Grants 2.17 Million Share Options Under 2026 Incentive Plan
PremiumCompany Announcements
Faron Pharmaceuticals Grants 2.17 Million Share Options Under 2026 Incentive Plan
3M ago
Analyst Reaffirms Buy on Faron Pharmaceuticals, Maintaining $10 Price Target on Strong Bexmarilimab Data
PremiumRatings
Analyst Reaffirms Buy on Faron Pharmaceuticals, Maintaining $10 Price Target on Strong Bexmarilimab Data
4M ago
Faron Registers New Treasury Shares to Support Potential Bond Conversions
PremiumCompany Announcements
Faron Registers New Treasury Shares to Support Potential Bond Conversions
4M ago
Faron Pharmaceuticals Fined by Nasdaq Helsinki Over Disclosure Delays
PremiumCompany AnnouncementsFaron Pharmaceuticals Fined by Nasdaq Helsinki Over Disclosure Delays
4M ago
Faron Pharmaceuticals Issues New Shares to Settle Convertible Bond Amortisations
Premium
Company Announcements
Faron Pharmaceuticals Issues New Shares to Settle Convertible Bond Amortisations
4M ago
Faron Pharmaceuticals Issues New Treasury Shares to Prepare for Bond Conversions
Premium
Company Announcements
Faron Pharmaceuticals Issues New Treasury Shares to Prepare for Bond Conversions
4M ago
Faron Pharmaceuticals Issues Additional Special Rights Linked to Bond Tranches
PremiumCompany Announcements
Faron Pharmaceuticals Issues Additional Special Rights Linked to Bond Tranches
4M ago
Faron Pharmaceuticals Ends Liquidity Deal as Share Trading Strengthens
PremiumCompany Announcements
Faron Pharmaceuticals Ends Liquidity Deal as Share Trading Strengthens
5M ago
Faron Pharmaceuticals Adds Veteran Biotech Dealmaker Golumbeski to Board
PremiumCompany Announcements
Faron Pharmaceuticals Adds Veteran Biotech Dealmaker Golumbeski to Board
5M ago
Analyst Reiterates Buy on Faron as Bexmarilimab Advances and Funding Extends Runway; $10 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Faron as Bexmarilimab Advances and Funding Extends Runway; $10 Price Target Maintained
5M ago
Faron AGM Backs Equity-Funding Flexibility and New Option Plan Amid Ongoing Losses
PremiumCompany AnnouncementsFaron AGM Backs Equity-Funding Flexibility and New Option Plan Amid Ongoing Losses
5M ago
Faron Resets Warrant Terms and Issues New Equity-Linked Instruments to IPF
Premium
Company Announcements
Faron Resets Warrant Terms and Issues New Equity-Linked Instruments to IPF
5M ago
Faron Finalizes Share Offering Registration, Boosting Free Float and Voting Base
Premium
Company Announcements
Faron Finalizes Share Offering Registration, Boosting Free Float and Voting Base
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >